Biphasic (Subtherapeutic) Levodopa-Induced Respiratory Dysfunction in Parkinson Disease
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received September 2, 2020
- Accepted November 19, 2020
- First Published January 25, 2021.
Article Versions
- Previous version (January 25, 2021 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Veerle A. van de Wetering-van Dongen, MSc,
- Alberto J. Espay, MD, MSc,
- Luca Marsili, MD, PhD,
- Andrea Sturchio, MD,
- Susanne Ten Holter, MD,
- Bastiaan R. Bloem, MD, PhD and
- Maarten J. Nijkrake, PhD
- Veerle A. van de Wetering-van Dongen, MSc,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Alberto J. Espay, MD, MSc,
Abbvie, Neuroderm, Neurocrine, Amneal, Acadia, Acorda, Kyowa Kirin, Sunovion, Lundbeck, and USWorldMeds.
NONE
NONE
Editorial board member of the Journal of ParkinsonÂs Disease, European Journal of Neurology, and JAMA Neurology
NONE
Lippincott Williams & Wilkins, Cambridge University Press, and Springer.
NONE
Abbvie, Neuroderm, Neurocrine, Amneal, Acadia, Acorda, Kyowa Kirin, Sunovion, Lundbeck, and USWorldMeds.
Acadia, Sunovion, USWorldMeds.
NONE
NONE
NONE
NIH
NONE
Michael J Fox Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Luca Marsili, MD, PhD,
NONE
NONE
NONE
(1) The Clinical neurologist International, Editorial Board member, 2018. (2) Frontiers Neurology, Review Editor, 2019 (3) Frontiers Neurology, Guest Associate Editor, 2020 (3) Journal of Clinical Movement Disorders, Editorial Board member, 2020.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Andrea Sturchio, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Susanne Ten Holter, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Bastiaan R. Bloem, MD, PhD and
(1) Abbvie (commercial entity); (2) Biogen(commercial entity); (3) UCB (commercial entity);
NONE
(1) AbbVie (speaker's fee) (commercial entity); (2) Zambon (speaker's fee) (commercial entity); (3) Bial (speaker's fee) (commercial entity); (4) Roche (speaker's fee) (commercial entity) (6) GE Healthcare(speaker's fee) (commercial entity)
(1) Journal of Parkinson's Disease, co-Editor in Chief (2010-present) (no compensation); (2)Practical Neurology, member editorial board (2018 - presnt)(no compensations) (3)Digital Biomarkers, member editorial board (2017- present (no compensations)
NONE
NONE
NONE
Zambon (commercial entity) UCB (commercial entity) Abbvie (commercial entity)
NONE
NONE
NONE
(1) UCB (commercial entity); (2) AbbVie (commercial entity); (3) Verily (commercial entity).
(1) A smartphone based, titrated exercise solution for patients with Parkinson's disease in daily life. Grant of ZonMw. Role: project leader. 2019 (2) Proactive and Integrated Management and Empowerment in ParkinsonÂs Disease (PRIME-PD). Grant of the Gatsby Foundation. Role: project leader. 2018 (3) Vibrating socks: a novel cueing intervention to reduce freezing of gait in ParkinsonÂs disease. Grant of the Michael J Fox Foundation. Role: project leader. 2018 (4) The PERSPECTIVE study: PERsonalized SPEeCh Therapy for actIVE conversation. Grant of the Michael J Fox Foundation. Role: project leader.
NONE
(1) Netherlands Organization for Scientific Research (non- profit entity); (2) Michael J Fox Foundation (non-profit entity); (3) Parkinson Vereniging (non-profit entity); (4) Stichting Parkinson Fonds (non-profit entity); (5) National Parkinson Foundation (non-profit entity); (6) Hersenstichting (non-profit entity) (7) Gatsby foundation (non-profit entity)
NONE
NONE
NONE
NONE
NONE
NONE
- Maarten J. Nijkrake, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Department of Rehabilitation (VAvdW-vD, MJN), Radboud University Medical Center, Donders Center for Brain, Cognition and Behavior, Nijmegen, the Netherlands; Department of Neurology (AJE, LM, AS), UC Gardner Neuroscience Institute, Gardner Center for Parkinson's Disease and Movement Disorders, University of Cincinnati, OH; and Department of Neurology (STH, BRB), Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Center of Expertise for Parkinson and Movement Disorders, Nijmegen, the Netherlands.
- Correspondence
Ms. van de Wetering-van Dongen veerle.vandewetering-vandongen{at}radboudumc.nl
Article usage
Cited By...
The Nerve!: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
The scientific and clinical basis for the treatment of Parkinson disease (2009)C. Warren Olanow, Matthew B. Stern, Kapil Sethi et al.Neurology, May 26, 2009 -
Article
DMPK gene DNA methylation levels are associated with muscular and respiratory profiles in DM1Cécilia Légaré, Gayle Overend, Simon-Pierre Guay et al.Neurology: Genetics, May 23, 2019 -
Article
X-linked myotubular myopathyA prospective international natural history studyMélanie Annoussamy, Charlotte Lilien, Teresa Gidaro et al.Neurology, March 22, 2019 -
Articles
An algorithm (decision tree) for the management of Parkinson’s disease (2001):Treatment GuidelinesC. Warren Olanow, Ray L. Watts, William C. Koller et al.Neurology, June 12, 2001